Resmed Inc. Announces Q3 Results for Fiscal Year 2026
Resmed Inc. reported its third quarter results for fiscal year 2026, showing an 11% year-over-year revenue growth, a 290 basis points increase in non-GAAP gross margin, and a 21% rise in earnings per share. The company emphasizes its focus on expanding care access and further developing digital health capabilities.
Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com